DB289

DRUG3 trials

Sponsors

Immtech Pharmaceuticals, Inc

Conditions

African TrypanosomiasisProphylactic Activity Against MalariaTrypanosomiasis, African

Phase 1

Prophylactic Antimalarial Activity of DB289 in Volunteers

CompletedNCT00408369

Immtech Pharmaceuticals, IncProphylactic Activity Against Malaria

Start: 2006-11-30End: 2007-11-30Target: 19Updated: 2008-01-29

Phase 2

A Trial of DB289 for the Treatment of Stage I African Trypanosomiasis

CompletedNCT00802594

Immtech Pharmaceuticals, IncTrypanosomiasis, African

Start: 2001-08-31End: 2004-11-30Updated: 2008-12-05

Trial of DB289 for the Treatment of Stage I African Trypanosomiasis

CompletedNCT00803933

Immtech Pharmaceuticals, IncAfrican Trypanosomiasis

Start: 2003-02-28End: 2005-06-30Updated: 2008-12-08